|4Jun 22, 9:00 AM ET

ContraVir Pharmaceuticals, Inc. 4

4 · ContraVir Pharmaceuticals, Inc. · Filed Jun 22, 2017

Insider Transaction Report

Form 4
Period: 2017-06-20
Cavan John T
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-06-20$0.65/sh+20,000$13,00020,000 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4